News
-
AMRI Receives NIH Contract Award For The Development Of Pre-Clinical Drug Candidates To Treat Diseases Of The Nervous System
8/21/2011
AMRI recently announced it received a federal contract award from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) to provide chemistry and other drug discovery technologies in support of NINDS’ Medicinal Chemistry for Neurotherapeutics Program (MCNP), part of the NIH Blueprint Neurotherapeutics Network.
-
New Two-Drug Approach To Treat Type Of Respiratory Disease
8/11/2011
A therapy combining two existing drugs could provide an effective new approach for treating patients with pleural infections, a serious condition where infected fluid builds up in the space between the ribs and lungs.
-
Virginia G. Piper Cancer Center, TGen Studying New Breast Cancer Drug
7/25/2011
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology (ASCO).
-
Pfizer Selects Exco InTouch To Enhance Patient Communication In Clinical Trials
6/29/2011
Exco InTouch, the leading mobile messaging provider for the pharmaceutical industry, announces that its text messaging technology ATLAS has been selected by Pfizer, one of the world's leading pharmaceutical companies to enhance the efficacy of its patient recruitment and retention in Phase I clinical trials.
This website uses cookies to ensure you get the best experience on our website. Learn more